Developing Medical Innovation

We develop new technologies from the NHS and beyond to improve patient care

Realising Potential

Medovate is a dynamic medical device company dedicated to the development and commercialisation of innovative medical technologies created within the NHS and beyond.

Medovate provides technical, management and financial support to develop medical devices through clinical trials, regulatory approval and market launch, in order to improve patient safety and healthcare delivery.

Our current pipeline of novel medical technologies is focussed on anaesthesia, airway, critical care and surgery.

** COVID-19 pandemic: Medovate remains fully operational during this time. Team members are fully able to work from home and can be contacted via phone and e-mail. Please see post in 'News' for full details.**

Read More

Latest News

Keep up to date with Medovate News & Events


Medovate’s game-changing anaesthesia device SAFIRA® receives European CE regulatory approval

15th September, 2020

Medovate – a pioneering medical device development company specialising in anaesthesia, airway management, critical care, and surgery – announced it has received CE Mark Approval for its game-changing medical device SAFIRA® (SAFer Injection for Regional Anaesthesia).


Medovate announces distribution agreement with LTR Medical for sales of SAFIRA® in Australia and New Zealand

8th September, 2020

Medovate has concluded a distribution agreement with Brisbane-based LTR Medical which will provide exclusivity for SAFIRA® in Australia and New Zealand.


Medovate named ‘2020’s Leading Innovators in Medical Device Development – the UK’

1st September, 2020

Cambridge-based medical device company Medovate has been named ‘2020’s Leading Innovators in Medical Device Development’ in Global Health & Pharma’s (GHP) 2020 Global Excellence Awards.